(A) Schematic of potential double-negative feedback loop between
DUX4 and NMD, in which DUX4 inhibits NMD and NMD degrades
DUX4 mRNA. (B) Levels of endogenously transcribed DUX4 mRNA
following control treatment or ectopic DUX4 expression,
measured 2 days after the initiation of myogenesis in FSHD1 (54-2) and FSHD2
(MB200) cells. (C) Relative levels of transcripts from the
Gl-DUX4-Intron2(+) and Gl-DUX4-Intron2(−) constructs following
control treatment or ectopic DUX4 expression in normal
myoblasts (54-1 cells). For each construct, data are normalized such that the
siControl treatment is 1. Error bars, standard deviation. (D)
Schematic of potential model of interactions between DUX4 and NMD in healthy
(top) and FSHD (bottom) muscle cells. In healthy cells, DUX4 mRNA is
efficiently degraded by NMD; in FSHD cells, DUX4 triggers proteolytic
degradation of UPF1 and inhibits NMD, resulting in the accumulation of DUX4
mRNA and protein.
DOI:
http://dx.doi.org/10.7554/eLife.04996.007